Biogen Inc. (0R1B.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 25.92B |
| Enterprise Value | 29.86B |
| P/E Ratio | 21.63 |
| PEG Ratio | -2.78 |
| Price/Sales Ratio | 3.03 |
| Price/Book Ratio | 1.6 |
| Enterprise/Revenue | 3.36 |
| Enterprise/EBITDA | 12.25 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.14 |
| Operating Margin | 0.16 |
AD
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | 0.08 |
Income Statement
| Revenue | 9.53B |
| Revenue/Share | 66.97 |
| Gross Profit | 6.45B |
| EBITDA | 3.32B |
| Net Income | 1.29B |
| Diluted EPS | 8.79 |
Balance Sheet
| Total Cash | 4.28B |
| Total Cash/Share | 29.09 |
| Total Debt | 6.56B |
| Total Debt/Equity | 0.35 |
| Current Ratio | 3.06 |
| Book Value Per Share | 126.71 |
Price History
| 52-Week Change | 52.74 |
| 52-Week High | 206 |
| 52-Week Low | 197.54 |
| Moving Average 50 Days | 197.9 |
| Moving Average 200 Days | 178.49 |
Statistics
| Average Volume | 1,676.42 |
| Shares Outstanding | 146.77M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
